Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions.

@article{Paller2013ManagementOB,
  title={Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions.},
  author={Channing J Paller and Emmanuel S Antonarakis},
  journal={Clinical advances in hematology & oncology : H&O},
  year={2013},
  volume={11 1},
  pages={
          14-23
        }
}
Among men treated with prostatectomy or radiation therapy for localized prostate cancer, the state of an increasing prostate-specific antigen (PSA) level is known as biochemical recurrence (BCR). BCR can be predictive of the development of subsequent distant metastases and ultimately death, but BCR often predates other signs of clinical progression by several years. Although patients may be concerned about their rising PSA levels, physicians attempting to address patient anxiety must inform… CONTINUE READING
Tweets
This paper has been referenced on Twitter 4 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 58 CITATIONS

FILTER CITATIONS BY YEAR

2013
2019

CITATION STATISTICS

  • 3 Highly Influenced Citations

  • Averaged 14 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 58 REFERENCES

Changes in PSA kinetics predict metastasis-free survival in men with PSA-recurrent prostate cancer treated with Paller and Antonarakis Page 9 Clin Adv Hematol Oncol

  • ES Antonarakis, ML Zahurak, J Lin, D Keizman, MA Carducci, MA. Eisenberger
  • Author manuscript; available in PMC April 12. N…
  • 2012

Similar Papers

Loading similar papers…